Navigation Links
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
Date:11/10/2008

ursuant to which Caliper will sublease approximately 10,000 square feet of manufacturing and office space to SOTAX on a market-rate basis starting in 2009.

-- Caliper Completed a Restructuring into Three Strategic Business Units to Sharpen Focus on Core Product Lines. During the third quarter, Caliper reorganized its various products and services along three core business areas -- Discovery Research (Research), Optical Molecular Imaging (Imaging), and Caliper Discovery Alliances and Services (CDAS) -- with the goal of creating a more scalable infrastructure while putting increased focus on growth and profitability.

-- Research is responsible for utilizing Caliper's core automation and microfluidic technologies to address an expanding array of opportunities in drug discovery and life science research, including molecular biology sample preparation for genomics, proteomics, cellular screening and forensics.

-- Imaging is responsible for expanding Caliper's global leadership position in the high growth optical molecular imaging market through expansion of therapeutic area applications of Caliper's IVIS(R) imaging platform, addressing critical discovery workflows and facilitating additional imaging modalities.

-- CDAS is responsible for expanding drug discovery collaborations and alliances, and increasing sales of drug discovery services. The focus of CDAS is to capitalize on market "outsourcing" trends and to maximize the large contract opportunity with the Environmental Protection Agency under its ToxCast screening program.

-- Reduced Operating Costs and Increased Productivity. The company benefited from cost savings initiatives implemented over the previous twelve months, including actions taken in the third quarter.

-- Upon the closing of the PDQ sale, approximately 23 Caliper employees transferred their employment positions to SOTAX. The total estimated annual cost associated with these employees is approximately $2.0 milli
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
2. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
3. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
6. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
7. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
8. Caliper Life Sciences Reports Second Quarter 2008 Results
9. Caliper Life Sciences Second Quarter 2008 Financial Results Conference Call Notice
10. Caliper Life Sciences Added to Russell 3000(R) Index
11. Caliper Life Sciences to Present at Deutsche Banks 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Pomerantz LLP is investigating claims on behalf of ... (NASDAQ: IPXL).  Such investors are advised to contact ... 888-476-6529, ext. 237. The investigation concerns whether ... violated Sections 10(b) and 20(a) of the Securities Exchange ... 2014, Impax Laboratories, Inc. (the "Company") issued a press ...
(Date:7/29/2014)... 29, 2014 According to the ... Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud ... & Trends to 2018", published by MarketsandMarkets, analyzes and ... such as North America , ... and the Rest of the World (RoW). ...
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- Nanosyn, Inc. ... FORMA Therapeutics, Inc., to provide access to Nanosyn,s ... lead discovery platform for novel small molecule therapeutics. ... the opportunity to work with FORMA Therapeutics to ... and protein homeostasis. FORMA Therapeutics, decision to work ...
(Date:7/29/2014)... July 29, 2014  Cannabis Science, Inc. (OTC: ... drug development and related consulting, applauds the Editorial ... a strong position in opposition to current federal ... 2014 publication.  The New York Times also announces ... week exploring the issue called "High Time:  An ...
Breaking Biology Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3
... Corgenix to serve as subcontractor to Battelle for ... related programsDENVER, Jan. 26 Corgenix Medical Corporation ... marketer of diagnostic test kits, has announced a ... and development organization whose business focus includes national ...
... BEIJING, Jan. 26 /PRNewswire-Asia/ -- Sinovac Biotech ... of vaccines in China, today,announced its wholly ... has obtained approval from China,s Ministry of ... developed inactivated animal rabies,vaccine with independent intellectual ...
... Jan. 26 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ... the efficacy portion of its initial Phase 3 clinical,trial ... the acute treatment of migraine. , ... the potential to be,both fast acting and long-lasting, providing ...
Cached Biology Technology:Corgenix Signs Collaboration With Battelle 2Corgenix Signs Collaboration With Battelle 3Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine 2Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine 3Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine 4MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine 2MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine 3
(Date:7/29/2014)... in locomotion. Swimming microorganisms, such as bacteria and spermatozoa, ... the viscous forces exerted by the surrounding fluid. ... scientists have found that the direction of propulsion made ... by a viscoelastic fluid. These findings have been published ... the Alternative Energies and Atomic Energy Commission (CEA), in ...
(Date:7/29/2014)... the Northern Territories in Canada and have sent smoke ... continue on. NASA,s Aqua satellite collected this natural-color ... on July 26, 2014. Actively burning areas, detected by ... of smoke are drifting northward in this image. ... Fire has caused power outages in the area ...
(Date:7/29/2014)... from scientists at the University of Kent has shown ... are regulated a breakthrough that could have a ... from Kent,s School of Biosciences uncovered the mechanism whereby ... known as actin filaments are ,fine-tuned, to ... filaments appear to completely stable, providing a framework for ...
Breaking Biology News(10 mins):Optimum inertial self-propulsion design for snowman-like nanorobot 2
... - can get you lost - quick. Tons of genes, tons ... being unknown, tons of database with tons of information... and your ... meaningfull way. Applications are being developped to make it all easier, ... I didn't have time to try it yet, but it seems ...
... approval to Mylan Technologies, Inc., for the first generic ... used to treat patients suffering from severe chronic pain ... to the skin, this patch technology delivers fentanyl, an ... body through the skin providing pain relief for up ...
... and Drug Administration (FDA) has granted approval to Mylan ... Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat ... managed with alternative analgesics. When applied to the skin, ... that is slowly absorbed into the body through the ...
Cached Biology News:GeneNotes - A novel information management software for biologists 2
... analysis of gene expression) technology ... Expression profiles generated by SAGE ... low-abundance transcripts making it possible ... I-SAGE Kit is designed to ...
Human LAIR2 Biotinylated Affinity Purified PAb...
... mycobacteria in Complete Freund's adjuvant attract macrophages ... which enhances the immuneresponse. For this reason, ... the initial injections; Incomplete Freund's adjuvant is ... in saline) are typically mixed with an ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
Biology Products: